Skip to content

How the androgen receptor, a protein, influences breast cancer treatment and impacts the patients future health.

Androgen receptor in breast cancer - clinical and prognostic outcomes - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069377
Enrollment
96
Registered
2024-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast

Interventions

Control Intervention1: nil: nil

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing surgery for breast cancer and specimen sent for IHC. Patient who underwent trucut and sent for IHC. All patients received treatment at KMC both for metastatic and non metastatic breast cancer. Patients consenting to be part of study. Patients above 18 years of age.

Exclusion criteria

Exclusion criteria: Age below 18 years. Patient not willing to participate in study. Male breast carcinoma. Other malignancy at the time of breast cancer diagnosis. Prior chemotherapy. Patient failing tofollow up.

Design outcomes

Primary

MeasureTime frame
Incidence of androgen receptor in breast cancer in our population. The correlation of Androgen receptors with other biomarkers. Prognosis and survival outcomes of the disease. The patient outcomes will be seen at 3rd month and 6th month of follow upTimepoint: To asses the oncological outcomes, response to treatment. The patient outcomes will be seen at 3rd month and 6th month of follow up

Secondary

MeasureTime frame
To correlate the AR status with the staging of the breast cancer.Timepoint: To asses the response to treatment response to treatment at 3rd & 6th month

Countries

India

Contacts

Public ContactDr. Sheena Wadhwa

Kasturba Medical college and Hospital

veena.karanth@manipal.edu9845417715

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026